Biotech Stocks
RayzeBio's $173M radiopharma plan; Lonza creates commercial chief position
Endpoints News
3h ago
$173M
RayzeBio plots new build: Bristol Myers Squibb's subsidiary plans to invest more than $173 million to construct a new 450,000-square-foot radiopharma factory in Whitestown, IN, with construction slated to start this ...
Discussion
Sign in to join the discussion. Comments loading…